ENDONOVO THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of $33.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2023-04-17
- ENDONOVO THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was $33.00M, a 17.86% increase from fiscal 2021.
- ENDONOVO THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2021 was $28.00M, a 4.09% increase from fiscal 2020.
- ENDONOVO THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2020 was $26.90M, a 6.75% increase from fiscal 2019.
- ENDONOVO THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2019 was $25.20M, a 16.67% increase from fiscal 2018.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2022-12-31 | $33.00M 10-K · filed 2023-04-17 | |
| 2021-12-31 | $28.00M 10-K · filed 2023-04-17 | $29.90M 10-K · filed 2022-04-14 |
| 2020-12-31 | $26.90M 10-K · filed 2022-04-14 | |
| 2019-12-31 | $25.20M 10-K · filed 2020-05-04 | |
| 2018-12-31 | $21.60M 10-K · filed 2019-04-15 | |
| 2017-12-31 | $14.00M 10-K · filed 2018-04-06 | |
| 2016-12-31 | $9.74M 10-K · filed 2017-04-17 |